Anti-Obesity Market Overview

The Business Research Company’s Antiobesity Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LANDON, GREATER LANDON, UK, January 19, 2024 /EINPresswire.com/ — Experiencing remarkable expansion, the anti-obesity market is poised to surge from $3.38 billion in 2023 to $3.76 billion in 2024, boasting a substantial Compound Annual Growth Rate (CAGR) of 11.3%. The growth momentum is anticipated to persist, reaching $5.64 billion by 2028, maintaining a robust CAGR of 10.7%.

Drivers Fueling Market Growth:
The prevalence rate of obesity is escalating globally, emerging as a significant public health concern. By 2030, it is estimated that over 1 billion people will grapple with obesity, fueled by factors such as increased consumption of processed and unhealthy foods, sedentary lifestyles, and insufficient awareness of obesity-related risks. This trend is expected to propel the demand for anti-obesity drugs, contributing to the anti-obesity market’s rapid growth.

Rising Geriatric Population as a Growth Catalyst:
The expanding geriatric population, typically aged 65 and older, is set to drive the growth of the anti-obesity drugs market. Elderly individuals, especially those with diabetes, face an elevated risk of obesity due to reduced physical activity and compromised blood circulation. With projections indicating a significant rise in the global elderly population, the demand for anti-obesity drugs is expected to surge.

Explore the Global Antiobesity Market with a Detailed Sample Report:

Key Players Shaping the Market Landscape:
Major companies such as F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Pfizer Inc., and Novo Nordisk A/S are pivotal in driving market dynamics. These key players contribute through innovative products, strategic collaborations, and a focus on addressing the evolving healthcare needs associated with obesity.

Innovations in Product Offerings:
Companies in the anti-obesity drugs market are actively pursuing product innovations, exemplified by Eli Lilly and Company’s launch of Mounjaro (tirzepatide). This injectable anti-obesity drug, approved by the FDA, caters to adults struggling with obesity, offering a valuable solution to achieve weight loss goals, particularly for those with type 2 diabetes.

Strategic Collaborations for Market Strength:
Strategic alliances, mergers, and acquisitions are becoming increasingly prevalent in the pharmaceutical industry. For instance, the collaboration between Evotec AG and Novo Nordisk aims to discover and develop drug molecules to treat metabolic disorders, including obesity and diabetes, reinforcing the industry’s commitment to launching safe and effective drugs in the market.

Regional Insights and Market Segmentation:
North America dominates the anti-obesity market in 2023, while the Middle East is anticipated to emerge as the fastest-growing region.
The antiobesity market covered in this report is segmented –
1) By Drug Class: Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs
2) By Type: Prescription Drugs (Rx), OTC Drugs
3) By Medication: Monotherapies, Polytherapies

Access the Complete Report for In-Depth Analysis:

Antiobesity Global Market Report 2024 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Antiobesity Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on antiobesity market size, antiobesity market drivers and trends, antiobesity market major players, competitors’ revenues, antiobesity market positioning, and antiobesity market growth across geographies. The antiobesity market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Weight Management Global Market Report 2023

Weight Loss and Diet Management Global Market Report 2023

Weight Loss Products And Services Global Market Report 2023

About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 6500+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn:
Twitter:
Facebook:
YouTube:
Blog:
Healthcare Blog:
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn

Elevate Your Space: Contract Furniture Market Insights, Growth Drivers, and Design Innovations! 🪑✨